SBE Council Statement on HHS’s Drug Importation Plan

By at 6 August, 2019, 9:45 am


Washington, D.C. – The U.S. Department of Health and Human Services (HHS) recently announced the  “Safe Importation Action Plan,” a proposal that provide a pathway for the importation of prescription drugs from Canada into the United States. Small Business & Entrepreneurship Council (SBE Council) president & CEO Karen Kerrigan released the following statement on the plan:

“Prescription drug importation is not safe for American consumers and will not lower costs. The proposal provides a government-supported pathway for unsafe and counterfeit drugs to enter the U.S. and into the hands of consumers. The federal government should be doing more to protect American consumers from dangerous drugs that are imported, not enabling their flow into the U.S. market. Consumers are at risk with this ‘gimmick,’ as Secretary Alex Azar referred to importation last year.  Importation undermines America’s intellectual property, our innovative capacity and global leadership in producing the next generation of life-saving drugs. And, as a reminder, small to mid-size companies dominate the U.S. pharmaceutical industry.  SBE Council strongly opposes this proposal, and is urging the Administration to turn to solutions that enable investment and competition, which will lower costs and incentivize innovation in this critical U.S. industry.”


Karen Kerrigan


SBE Council is nonpartisan advocacy, research and education organization dedicated to protecting small business and promoting entrepreneurship. For 25 years, SBE Council has worked on and advanced a range of private sector and public policy initiatives to strengthen the ecosystem for strong startup activity and small business growth. Visit for additional information. Twitter: @SBECouncil



News and Media Releases